Evidence map›Paper›PMID 32673006›Full record

Trial reportPsychological trauma : theory, research, practice and policy2021

Does exposure exacerbate symptoms in veterans with PTSD and alcohol use disorder?

Jessica C Tripp, Moira Haller, Ryan S Trim, Elizabeth Straus, Craig J Bryan, Brittany C Davis, Robert Lyons, Jessica L Hamblen, Sonya B Norman

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychological trauma : theory, research, practice and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jessica C TrippVA San Diego Healthcare System.ORCID 0000-0001-5836-629X
Moira HallerVA San Diego Healthcare System.
Ryan S TrimVA San Diego Healthcare System.
Elizabeth StrausVA San Diego Healthcare System.
Craig J BryanNational Center for Veterans Studies.
Brittany C DavisJames A. Haley Veteran's Hospital.
Robert LyonsVA San Diego Healthcare System.
Jessica L HamblenNational Center for PTSD.
Sonya B NormanNational Center for PTSD.
VA San Diego Healthcare System · USNational Center for PTSD · USJames A. Haley Veterans' Hospital · US

Funding

Integrated Alcohol Disorder and PTSD TreatmentI01CX000756 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI NORMAN, SONYA · 2013 to 2017
–
CSRD VA I01 CX000756Veterans Affairs Clinical Science Research and Development
6 · The paper itself

Abstract

objectivePatients with posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) are often not offered exposure therapy for PTSD due to concerns that symptoms may worsen. This study examined whether initiating exposure would cause exacerbation of PTSD, alcohol use, depression, or suicidal ideation (SI) among patients with PTSD/AUD participating in exposure therapy for PTSD.

methodVeterans were randomized to either concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE) or seeking safety, a nonexposure intervention, and were included in this study if they had data to at least Session 5 available (n = 81). They completed measures of PTSD, alcohol use, and depression/SI symptom severity throughout treatment and posttreatment. The reliable exacerbation method examined the number of participants who demonstrated clinically meaningful symptom exacerbation from Sessions 3 to 5 (capturing the prepost window for the start of exposure in COPE). Hierarchical/logistic regressions examined whether treatment condition predicted exacerbation of symptoms. T tests/chi-square analyses examined whether clinical exacerbation led to worse posttreatment outcomes.

resultsFew participants endorsed exacerbation in symptoms of PTSD (15.8%), alcohol use (5.1%), depression (10.2%), or SI (12.8%). No significant treatment condition differences existed. Participants who experienced symptom exacerbation had higher rates of depression posttreatment compared to those who did not experience symptom exacerbation, but there were no differences in PTSD, alcohol use, or SI.

conclusionsExposure therapy did not lead to more clinical exacerbation than nonexposure therapy during the course of treatment, providing support that exposure therapy should not be withheld from patients with PTSD/AUD. This was a secondary analysis. and future studies that are sufficiently powered may demonstrate different results. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Indexed as

AlcoholismImplosive TherapyStress Disorders, Post-TraumaticVeteransHumansSuicidal Ideation

Identifiers

PMID32673006
PMCPMC8454212
OpenAlexW3043324584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.